Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/5503
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAbdigaffar G. Gadayev., Matluba E. Rakhimova., Yulduz B. Bakhronova-
dc.date.accessioned2026-10-17T15:16:11Z-
dc.date.available2026-10-17T15:16:11Z-
dc.date.issued2026-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/5503-
dc.description.abstractBackground. Renal dysfunction substantially worsens the prognosis of patients with heart failure (HF). Endothelial glycocalyx degradation has recently emerged as a key mechanism underlying cardiorenal syndrome, while syndecan-1 has gained attention as a circulating biomarker of endothelial injury. However, its relationship with renal dysfunction and cardiac hemodynamics in HF remains insufficiently characterized. Objective. To evaluate the association between serum syndecan-1 concentrations and cystatin C-based renal function, cardiac hemodynamic parameters, inflammatory biomarkers, and to determine its diagnostic value for the early detection of renal dysfunction in patients with chronic heart failure (CHF).en_US
dc.language.isoen_USen_US
dc.publisherO'zbekiston, Toshkent (Central Asian Journal of Medicine) № 7en_US
dc.relation.ispartofseriesUDC;616.379-008.64:616-092.18-
dc.subjectchronic heart failure; cardiorenal syndrome; syndecan-1; endothelial glycocalyx; cystatin C; renal dysfunction; NT-proBNP; biomarkers.en_US
dc.titleDIAGNOSTIC VALUE OF SYNDECAN-1 FOR EARLY DETECTION OF RENAL DYSFUNCTION AND ITS ASSOCIATION WITH CARDIAC HEMODYNAMIC AND BIOCHEMICAL PARAMETERS IN HEART FAILUREen_US
dc.typeArticleen_US
Appears in Collections:

Files in This Item:
File Description SizeFormat 
CAJM.pdf10.08 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.